Figure 2

Changes in plasma lutein concentration in a total of 39 unilateral age-related macular degeneration patients (A) and the beeswax capsule group (n = 20) and glycerol fatty acid esters capsule group (n = 19) (B). Comparison of difference from the baseline in the beeswax capsule group (n = 20) and glycerol fatty acid esters capsule group (n = 19) (C). (A) Plasma lutein concentration significantly increased from the baseline at 3 months and 6 months (repeated measures ANOVA, p < 0.0001). (B) The plasma lutein concentrations significantly increased at 3 and 6 months from the baseline in the beeswax capsule group (repeated measures ANOVA, p < 0.0001) and at 6 months from the baseline in the glycerol fatty acid esters capsule group (repeated measures ANOVA, p = 0.0015). (C) No significant differences were seen between the two capsule groups at 3 and 6 months (ANCOVA; p = 0.0668 and p = 0.5171, respectively). SE = standard error.